| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |